Duplicate_Yokohama City University Medical Center /ID# 163907

Yokohama, Kanagawa 232-0024

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease — Running, not enrolling